Value, page-37

From Wisdomsofsilence 26/11/11 SP 46.5

"In this trial of difficult-to-treat patients, 82% were completely or partially healed with an average reduction in skin ulcer area of 56%. Given that these 44 patients had on average not responded to 3 years of expert care, these are superb results."

Superb results indeed that would not have gone un-noticed!

Its a matter of when, not if, a takeover is launched, and this announcement today facilitates that perfectly IMO, as has been alluded to in the ann:

"b) Enhanced position in merger / strategic alliance negotiations with pharma due to fully integrated
commercialisation infrastructure and lack of contractual restraints"